Quantum Windbag
Gold Member
- May 9, 2010
- 58,308
- 5,101
- 245
Of course they are, but that won't change the minds of its defenders.
Government Overreach Threatens Lives | Hoover Institution
Stem-cell treatment.
In light of all these difficulties, it is absolutely critical that the FDA should not be allowed to extend its power over new drugs and devices to regulate the practice of medicine, where it is singularly ill-equipped to intervene. Unfortunately, the FDA has sought with some success to insert itself into the regulation of medical practice in the highly promising area of stem-cell technology.
In the 2012 watershed decision Regenerative Sciences LLC v. United States, Judge Rosemary Collyer sustained the FDAs asserted control of this entire area. Now that her decision is on appeal, I have attacked her opinion at length in my essay for the Manhattan Institute, The FDAs Misguided Regulation of Stem-Cell Procedures: How Administrative Overreach Blocks Medical Innovation.
It is widely recognized that stem-cell therapies hold the key to the next generation of medical advances in connection with such devastating conditions such as leukemia and Parkinsons diseases. It is also common ground in the medical profession that so-called allogenic treatments, whereby stem-cells from one person are ultimately transferred into the body of another, run the risk of immunological rejection by the recipient. The preferred road to medical advance lies therefore through autologous transfers that remove your own cells, which are then manipulated under laboratory conditions to grow new tissue forms that can then be reinjected into your body to restore its lost function.
Government Overreach Threatens Lives | Hoover Institution